Epirubicin-Adsorbed Nanodiamonds Kill Chemoresistant Hepatic Cancer Stem Cells (ACS Nano, Dec 2014)

Xin Wang †, Xinyi Casuarine Low †, Weixin Hou ‡,Lissa Nurrul Abdullah ‡, Tan Boon Toh ‡, Masturah Mohd Abdul Rashid †, Dean Ho §, and Edward Kai-Hua Chow *†‡ † Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 117597Singapore ‡ Cancer Science Institute of Singapore, Yong Loo Lin School

STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation (Cell Res, Nov 2014)

Sheng W1, Yang F2, Zhou Y3, Yang H2, Low PY4, Kemeny DM4, Tan P5, Moh A6, Kaplan MH7, Zhang Y4, Fu XY8. 11] Cancer Science Institute of Singapore, YLL School of Medicine, National University of Singapore, Singapore [2] Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore. 2Cancer Science Institute of Singapore,

CSI scientists selected to attend HOPE meetings with Nobel Laureates 2015

CSI is proud to have two researchers selected to attend the HOPE Meetings with Nobel Laureates, organised by the Japan Society for the Promotion of Science (JSPS) from 1 – 5 March 2015. Special Fellow Dr Touati Benoukraf and 4th year PhD student Xu Liang are among the 75 candidates carefully chosen across the Asia-Pacific

Channel NewsAsia interviews Dr. Ruby Huang on novel study to index EMT in cancer progression

Dr. Ruby Huang, Principal Associate at the Cancer Science Institute of Singapore, was recently interviewed live by leading Asian news provider Channel NewsAsia on 13th November 2014. In the segment, Dr. Huang discussed how research conducted in CSI resulted in a novel method to score Epithelial-Mesenchymal Transition (EMT) in cancer progression. Led by Dr Ruby